BioMarin Pharmaceutical

NASDAQ
BMRN
Stock
Yield per half year: -11.3%
Dividend yield: 0%
Sector: Healthcare

57.55 $

0 $ 0%
55.89 $
93.84 $

Min/max per year

Share chart BioMarin Pharmaceutical

About BioMarin Pharmaceutical

BioMarin Pharmaceutical Inc.  — американская биотехнологическая компания со штаб-квартирой в Сан-Рафаэле, Калифорния . У него есть офисы и помещения в США , Южной Америке , Азии и Европе . Основным направлением деятельности и исследованиями BioMarin является заместительная терапия ферментами (ФЗТ).

more details
 BioMarin была первой компанией, которая предоставила терапевтические средства для лечения мукополисахаридоза типа I (MPS I), производя ларонидазу ( Aldurazyme , коммерциализируется Genzyme Corporation). BioMarin также была первой компанией, которая начала предлагать препараты для лечения фенилкетонурии.

Main settings

IPO date
1999-07-23
ISIN
US09061G1013
Industry
Biotechnology
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Див.доход ао
0
Сайт

Grade

Underestimation
Title Value Grade
P/S 4.51 3
P/BV 2.28 6
P/E 30.16 5
Efficiency
Title Value Grade
ROA 6.17 2
ROE 8.05 3
ROIC 0.79 1
Dividends
Title Value Grade
Dividend yield 0 0
DSI 0 0
Average dividend growth 0 0
Debt
Title Value Grade
Debt/EBITDA 0.9265 9
Debt/Ratio 0.0862 10
Debt/Equity 0.2352 10
Growth impulse
Title Value Grade
Yield Revenue, % 53.44 7
Yield Ebitda, % -11125.9 0
Yield EPS, % -51.56 0

Prices

Price Min. Max. Change Changes in the industry Changes in the index
Yesterday 57.55 $ 0 $ 0 $ 0 % 0 % 0 %
Week 59.41 $ 0 $ 0 $ -3.13 % 0 % 0 %
Month 62.74 $ 57.55 $ 59.93 $ -8.27 % 0 % 0 %
Three month 69.01 $ 55.89 $ 72.83 $ -16.6 % 0 % 0 %
Half a year 64.88 $ 55.89 $ 72.83 $ -11.3 % 0 % 0 %
Year 75.52 $ 55.89 $ 93.84 $ -23.8 % 0 % 0 %
3 years 72.42 $ 55.89 $ 117.27 $ -20.53 % 0 % 0 %
5 years 82.93 $ 55.89 $ 131.03 $ -30.6 % 0 % 0 %
10 years 80.61 $ 55.89 $ 149.09 $ -28.61 % 0 % 0 %
Year to date 66.01 $ 55.89 $ 72.83 $ -12.82 % 0 % 0 %

Insider trading

Insider Transaction date Date of disclosure Type Price Volume Quantity Share before, % Share after, % Document
Burkhart Erin
GVP, Chief Accounting Officer
20.05.2025 20.05.2025 Sale 59.31 105 928 1786 0 0 link
Burkhart Erin
GVP, Chief Accounting Officer
19.03.2025 20.03.2025 Sale 71.52 92 618 1295 0 0 link
Burkhart Erin
GVP, Chief Accounting Officer
24.02.2025 25.02.2025 Sale 68.38 91 903 1344 0 0 link
Guyer Charles Greg
Officer
12.11.2024 12.11.2024 Purchase 66.37 350 301 5278 0 0 link
BIENAIME JEAN JACQUES
Director
10.05.2024 13.05.2024 Sale 81.14 1 622 800 20000 0 -0.01 link
BIENAIME JEAN JACQUES
Director
10.05.2024 13.05.2024 Purchase 63.1 1 262 000 20000 0 0.01 link
BIENAIME JEAN JACQUES
Director
09.05.2024 13.05.2024 Sale 81.62 1 632 400 20000 0 -0.01 link
BIENAIME JEAN JACQUES
Director
09.05.2024 13.05.2024 Purchase 63.1 1 262 000 20000 0 0.01 link
BIENAIME JEAN JACQUES
Director
12.04.2024 15.04.2024 Sale 91.26 1 825 200 20000 0 -0.01 link
BIENAIME JEAN JACQUES
Director
12.04.2024 15.04.2024 Purchase 63.1 1 262 000 20000 0 0.01 link
BIENAIME JEAN JACQUES
Director
11.04.2024 15.04.2024 Sale 90.99 1 819 800 20000 0 -0.01 link
BIENAIME JEAN JACQUES
Director
11.04.2024 15.04.2024 Purchase 63.1 1 262 000 20000 0 0.01 link
Burkhart Erin
GVP, Chief Accounting Officer
10.04.2024 12.04.2024 Sale 90 205 740 2286 0 0 link
BIENAIME JEAN JACQUES
Director
10.01.2024 11.01.2024 Sale 96.38 963 800 10000 0 -0.01 link
BIENAIME JEAN JACQUES
Director
10.01.2024 11.01.2024 Purchase 63.1 631 000 10000 0 0.01 link
BIENAIME JEAN JACQUES
Director
09.01.2024 11.01.2024 Sale 98.19 981 900 10000 0 -0.01 link
BIENAIME JEAN JACQUES
Director
09.01.2024 11.01.2024 Purchase 63.1 631 000 10000 0 0.01 link
Davis George Eric
EVP, Chief Legal Officer
13.12.2023 14.12.2023 Sale 95.3 1 311 710 13764 0 -0.01 link
BIENAIME JEAN JACQUES
Chief Executive Officer
08.08.2023 09.08.2023 Sale 88.29 529 740 6000 0 0 link
Davis George Eric
EVP, Chief Legal Officer
08.08.2023 09.08.2023 Sale 89.42 983 620 11000 0 -0.01 link
BIENAIME JEAN JACQUES
Chief Executive Officer
07.08.2023 09.08.2023 Sale 88.1 352 400 4000 0 0 link
BIENAIME JEAN JACQUES
Chief Executive Officer
10.05.2023 11.05.2023 Sale 94.85 2 845 500 30000 0 -0.02 link
BIENAIME JEAN JACQUES
Chief Executive Officer
10.05.2023 11.05.2023 Purchase 67.81 2 034 300 30000 0 0.02 link
BIENAIME JEAN JACQUES
Chief Executive Officer
09.05.2023 11.05.2023 Sale 94.93 2 847 900 30000 0 -0.02 link
BIENAIME JEAN JACQUES
Chief Executive Officer
09.05.2023 11.05.2023 Purchase 67.81 2 034 300 30000 0 0.02 link
BIENAIME JEAN JACQUES
Chief Executive Officer
06.04.2023 10.04.2023 Sale 96.13 961 300 10000 0 -0.01 link
BIENAIME JEAN JACQUES
Chief Executive Officer
06.04.2023 10.04.2023 Purchase 67.81 678 100 10000 0 0.01 link
Ajer Jeffrey Robert
EVP, Chief Commercial Officer
25.01.2023 27.01.2023 Sale 115.7 5 669 300 49000 0 -0.03 link
Ajer Jeffrey Robert
EVP, Chief Commercial Officer
25.01.2023 27.01.2023 Purchase 67.81 3 322 690 49000 0 0.03 link
BIENAIME JEAN JACQUES
Chief Executive Officer
14.10.2022 18.10.2022 Sale 89.89 359 560 4000 0 0 link

Main owners

Institutions Volume Share, %
PRIMECAP Management Company 18 414 374 9.76
Vanguard Group Inc 18 050 062 9.57
Blackrock Inc. 14 681 644 7.78
Dodge & Cox Inc 13 994 063 7.42
Capital Research Global Investors 10 774 641 5.71
State Street Corporation 6 730 515 3.57
Ameriprise Financial, Inc. 5 419 366 2.87
Barclays PLC 5 288 893 2.8
Viking Global Investors, L.P. 4 889 454 2.59
Avoro Capital Advisors LLC 4 300 000 2.28

Contained in ETF

ETF Share, % Profitability for 1 year, % Commission, %
VictoryShares Nasdaq Next 50 ETF 1.38305 3.94 0.18
iShares Evolved U.S. Innovative Healthcare ETF 1.35 0.000586 0.18
Future Tech ETF 1.30612 -18.13 0.35
Principal Healthcare Innovators ETF 1.30612 -3.92 0.35
IQ Engender Equality ETF 1.03522 7.62 0.45
GraniteShares XOUT U.S. Large Cap ETF 0.86381 -25.71 0.60
Syntax Stratified MidCap ETF 0.34133 -1.54 0.35
iShares Morningstar Mid-Cap Growth ETF 0.24673 441.88 0.06
iShares Morningstar Mid-Cap ETF 0.12333 252.83 0.04
iShares Morningstar Large-Cap Growth ETF 0.05463 264.7 0.04
iShares Morningstar Large-Cap ETF 0.0266 184.21 0.03
Columbia U.S. ESG Equity Income ETF 0.02348 -3.6 0.35

Similar companies



Company management

Head Job title Payment Year of birth
Mr. Brian R. Mueller CFO & Executive VP 1.15M 1974 (51 year)
Mr. George Eric Davis Executive VP, Chief Legal Officer, General Counsel & Secretary 1.23M 1971 (54 years)
Ms. Erin Burkhart Group VP & Chief Accounting Officer N/A 1979 (46 years)
Mr. Alexander Hardy President, CEO & Director N/A 1969 (56 years)
Dr. C. Greg Guyer Ph.D. Executive VP & CTO 1962 (63 years)
Dr. Kevin Eggan Ph.D. Chief Scientific Officer & Senior VP of Research and Early Development
Traci McCarty Group Vice President of Investor Relations
Ms. Humaira Serajuddin Senior VP & Chief Marketing Officer
Ms. Amy Wireman Executive VP & Chief People Officer

About company

Address: United States, San Rafael, 770 Lindaro Street - Open in google maps, Open in yandex maps
Website: http://www.biomarin.com